129 related articles for article (PubMed ID: 28825123)
21. Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis.
Hasanjani Roushan MR; Bayani M; Soleimani Amiri S; Mohammadnia-Afrouzi M; Nouri HR; Ebrahimpour S
J Biol Regul Homeost Agents; 2016; 30(3):675-682. PubMed ID: 27655484
[TBL] [Abstract][Full Text] [Related]
22. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic role of cytomegalovirus in medulloblastoma?
Hortal AM; Vermeulen JF; Van Hecke W; Bovenschen N
Cancer Lett; 2017 Nov; 408():55-59. PubMed ID: 28844716
[TBL] [Abstract][Full Text] [Related]
24. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
[TBL] [Abstract][Full Text] [Related]
26. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy.
Nobrega C; Horta A; Coutinho-Teixeira V; Martins-Ribeiro A; Baldaia A; Rb-Silva R; Santos CL; Sarmento-Castro R; Correia-Neves M
AIDS; 2016 May; 30(8):1175-86. PubMed ID: 26919738
[TBL] [Abstract][Full Text] [Related]
28. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
29. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
30. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
[TBL] [Abstract][Full Text] [Related]
31. High frequency of regulatory T cells among HIV type 1-infected men who have sex with men correlates with disease progression.
Wang WH; Ming L; Wang Y; Kan QC; Zhang XY
Chin Med J (Engl); 2013; 126(11):2054-61. PubMed ID: 23769557
[TBL] [Abstract][Full Text] [Related]
32. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo expanded regulatory T cells CD4
Lifshitz GV; Zhdanov DD; Lokhonina AV; Eliseeva DD; Lyssuck EY; Zavalishin IA; Bykovskaia SN
Autoimmunity; 2016 Sep; 49(6):388-396. PubMed ID: 27424664
[TBL] [Abstract][Full Text] [Related]
34. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G
Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398
[TBL] [Abstract][Full Text] [Related]
35. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
36. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
37. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic outcomes of medulloblastoma in Casablanca from 2000 to 2012].
Elbachiri M; Dao A; Jabir H; Sahraoui S; Taleb A; Bouchbika Z; Benchakroun N; Jouhadi H; Tawfiq N; Benider A
Cancer Radiother; 2015 Dec; 19(8):718-24. PubMed ID: 26563873
[TBL] [Abstract][Full Text] [Related]
39. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
[TBL] [Abstract][Full Text] [Related]
40. High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
Bergthold G; El Kababri M; Varlet P; Dhermain F; Sainte-Rose C; Raquin MA; Kieffer V; Goma G; Grill J; Valteau-Couanet D; Dufour C
Pediatr Blood Cancer; 2014 May; 61(5):907-12. PubMed ID: 24470384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]